Time to Achieve a Prostate Specific Antigen Nadir of 0.2 Ng./ml. After Simultaneous Irradiation For Prostate Cancer
Author:
Affiliation:
1. From the Radiotherapy Clinics of Georgia, Decatur, Georgia
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference8 articles.
1. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?;Amling;J Urol,2001
2. A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition;Critz;J Urol,2002
3. The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate cancer;Vicini;Cancer,2000
4. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy;Oesterling;J Urol,1988
5. Patterns and fate of PSA bouncing following 3D-CRT;Hanlon;Int J Radiat Oncol Biol Phys,2001
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy;Brachytherapy;2021-01
2. Surrogate endpoints in early prostate cancer research;Translational Andrology and Urology;2018-06
3. Prostate-specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low-dose-rate brachytherapy or external beam radiotherapy for localized prostate cancer;Cancer Medicine;2018-03-25
4. Long-Term Prostate Specific Antigen Stability and Predictive Factors of Failure after Permanent Seed Prostate Brachytherapy;Journal of Urology;2018-01
5. Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?;Frontiers in Oncology;2017-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3